Skip to content
2000
Volume 6, Issue 3
  • ISSN: 2211-5501
  • E-ISSN: 2211-551X

Abstract

Background: Plant natural products (PNPs) play a key role in human health and life quality through the treatment of diseases and as supplements in the food and healthcare industry. These high-value metabolites are traditionally extracted from the natural resource, but ongoing research is exploring the possibilities to construct efficient microbial cell factories that can replace current production methods. Objective: This review describes recent progress for producing PNPs in S. cerevisiae. Conclusion: Various PNPs, including stillbenoids, flavonoids, terpenoids and glucosinolates can now be produced in the baker's yeast Saccharomyces cerevisiae. As a result of the growing interest in the expression of plant biosynthetic pathways in yeast, many studies have aimed at developing platform strains delivering an improved supply of precursor metabolites. Synthetic biology tools facilitate the identification of superior enzymes, balance gene expression levels in the pathway, and enable the spatial arrangement of plant-derived enzymes in yeast to optimize the performance of the introduced pathways even further. Perspectives: The entry of CRISPR/Cas9 based technologies may allow other yeast species or filamentous fungi to be engineered for the production of PNPs.

Loading

Article metrics loading...

/content/journals/cbiot/10.2174/2211550105666160618123829
2017-08-01
2025-09-05
Loading full text...

Full text loading...

/content/journals/cbiot/10.2174/2211550105666160618123829
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test